Sugar Beets in South Dakota

At the close of the work for 1897 it became evident that no further progress could be made in determining the saccharine strength of beets grown in this state. The results were all that could be desired in every way. It was suggested, however, by factory builders and intending investors that the securing of commercial data was necessary. It was suggested that our \u27next need was to ascertain the cost per acre of producing the beets, and also to determine the tonnage from large plats where the beets were all harvested and weighed, in order that commercial conditions might be obtained. At the same time Dr. H. W. Wiley, Chief Chemist, United States Department of Agriculture, suggested the same line of work for this Station to follow. Also, since the sugar beet investigation for the United States had been placed in his charge he offered to furnish us with the necessary seed and to give any other assistance in his power. Urged by these considerations, this Station again resumed the experiments with sugar beets. It was deemed best to confine the work to a few localities rather than to send the seed promiscuously over the State. Preferably those localities were selected which had been making efforts towards securing sugar factories. In pursuance of this policy five points were selected, viz, Aberdeen, Huron, Yankton, Sioux Falls, and Brookings. Committees were selected in each locality and advised to organize and to make united efforts to obtain the commercial data required. In each place the committee elected a president and secretary, and entered upon the work with hearty good will. The seed furnished to this Station by the Department of Agriculture, through the kindness of Dr. Wiley, was distributed to these different committees. Instructions for preparing the ground, sowing, cultivating, and thinning were furnished to the committees. It was the intention of the writer to visit these different stations during the season. He was able to inspect the plants grown at th1ee of them. The committees were urged to obtain photographs and to make their data as full and explicit as possible, since it was the expectation to discontinue this work at the close of the present season. Photographs of some of the plants grown have been secured and will appear in their appropriate places in this Bulletin

Approach to the semiconductor cavity QED in high-Q regimes with q-deformed boson

The high density Frenkel exciton which interacts with a single mode microcavity field is dealed with in the framework of the q-deformed boson. It is shown that the q-defomation of bosonic commutation relations is satisfied naturally by the exciton operators when the low density limit is deviated. An analytical expression of the physical spectrum for the exciton is given by using of the dressed states of the cavity field and the exciton. We also give the numerical study and compare the theoretical results with the experimental resultsComment: 6 pages, 2 figure

Electronic structure, phase stability and chemical bonding in Th2_2Al and Th2_2AlH4_4

We present the results of theoretical investigation on the electronic structure, bonding nature and ground state properties of Th$_2$Al and Th$_2$AlH$_4$ using generalized-gradient-corrected first-principles full-potential density-functional calculations. Th$_2$AlH$_4$ has been reported to violate the "2 \AA rule" of H-H separation in hydrides. From our total energy as well as force-minimization calculations, we found a shortest H-H separation of 1.95 {\AA} in accordance with recent high resolution powder neutron diffraction experiments. When the Th$_2$Al matrix is hydrogenated, the volume expansion is highly anisotropic, which is quite opposite to other hydrides having the same crystal structure. The bonding nature of these materials are analyzed from the density of states, crystal-orbital Hamiltonian population and valence-charge-density analyses. Our calculation predicts different nature of bonding for the H atoms along $a$ and $c$. The strongest bonding in Th$_2$AlH$_4$ is between Th and H along $c$ which form dumb-bell shaped H-Th-H subunits. Due to this strong covalent interaction there is very small amount of electrons present between H atoms along $c$ which makes repulsive interaction between the H atoms smaller and this is the precise reason why the 2 {\AA} rule is violated. The large difference in the interatomic distances between the interstitial region where one can accommodate H in the $ac$ and $ab$ planes along with the strong covalent interaction between Th and H are the main reasons for highly anisotropic volume expansion on hydrogenation of Th$_2$Al.Comment: 14 pages, 9 figure

Density pertubation of unparticle dark matter in the flat Universe

The unparticle has been suggested as a candidate of dark matter. We investigated the growth rate of the density perturbation for the unparticle dark matter in the flat Universe. First, we consider the model in which unparticle is the sole dark matter and find that the growth factor can be approximated well by $f=(1+3\omega_u)\Omega^{\gamma}_u$, where $\omega_u$ is the equation of state of unparticle. Our results show that the presence of $\omega_u$ modifies the behavior of the growth factor $f$. For the second model where unparticle co-exists with cold dark matter, the growth factor has a new approximation $f=(1+3\omega_u)\Omega^{\gamma}_u+\alpha \Omega_m$ and $\alpha$ is a function of $\omega_u$. Thus the growth factor of unparticle is quite different from that of usual dark matter. These information can help us know more about unparticle and the early evolution of the Universe.Comment: 6pages, 4 figures, accepted for publication in Eur. Phys. J.

Chaos assisted tunnelling with cold atoms

In the context of quantum chaos, both theory and numerical analysis predict large fluctuations of the tunnelling transition probabilities when irregular dynamics is present at the classical level. We consider here the non-dissipative quantum evolution of cold atoms trapped in a time-dependent modulated periodic potential generated by two laser beams. We give some precise guidelines for the observation of chaos assisted tunnelling between invariant phase space structures paired by time-reversal symmetry.Comment: submitted to Phys. Rev. E ; 16 pages, 13 figures; figures of better quality can be found at http://www.phys.univ-tours.fr/~mouchet

Guidelines for chemotherapy of biliary tract and ampullary carcinomas

Few randomized controlled trials (RCTs) with large numbers of patients have been conducted to date in patients with biliary tract cancer, and standard chemotherapy has not been established yet. In this article we review previous studies and clinical trials regarding chemotherapy for unresectable biliary tract cancer, and we present guidelines for the appropriate use of chemotherapy in patients with biliary tract cancer. According to an RCT comparing chemotherapy and best supportive care for these patients, survival was significantly longer and quality of life was significantly better in the chemotherapy group than in the control group. Thus, chemotherapy for patients with biliary tract cancer seems to be a significant treatment of choice. However, chemotherapy for patients with biliary tract cancer should be indicated for those with unresectable, locally advanced disease or distant metastasis, or for those with recurrence after resection. That is why making the diagnosis of unresectable disease should be done with greatest care. As a rule, pathological diagnosis, including cytology or histopathological diagnosis, is preferable. Chemotherapy is recommended in patients with a good general condition, because in patients with general deterioration, such as those with a performance status of 2 or 3 or those with insufficient biliary decompression, the benefit of chemotherapy is limited. As chemotherapy for unresectable biliary tract cancer, the use of gemcitabine or tegafur/gimeracil/oteracil potassium is recommended. As postoperative adjuvant chemotherapy, no effective adjuvant therapy has been established at the present time. It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment